• Repaglinide in IFN-I Assay Design

  2026-10-01

  Repaglinide is presented here as an exploratory metabolic-context perturbation—not as an HDAC3 inhibitor or cancer treatment—in studies of interferon signaling and immune checkpoint resistance. The workflow pairs controlled drug exposure with RUNX2, cGAS–STING, IFNB1, chromatin, and immune readouts to separate metabolic effects from the epigenetic mechanism reported in osteosarcoma.

• Cy3 NHS Ester (Non-Sulfonated) Protocol Guide

  2026-10-01

  Cy3 NHS ester (non-sulfonated) provides a practical route for orange fluorescent labeling of accessible amino groups on proteins, peptides, and oligonucleotides when an organic co-solvent is acceptable. It is not water-soluble, so aqueous-only workflows and solvent-sensitive biomolecules should be evaluated with a sulfonated Cy3 NHS ester instead.

• SCH772984: ERK1/2 Inhibitor Workflow

  2026-09-30

  SCH772984 provides a selective way to interrogate ERK1/2 signaling in MAPK-driven cancer models, with practical applications spanning target engagement, proliferation assays, radiation-response studies, and xenograft research. This guide connects its established pharmacology with a testable workflow for studying HIF-1α-linked radioresistance without overstating evidence from nasopharyngeal carcinoma models.

• Erlotinib: Decoding EGFR–SCUBE3 Signaling

  2026-09-30

  Erlotinib and NSC 718781 provide a precise way to interrogate EGFR dependence while separating receptor-proximal signaling from SCUBE3-driven resistance and immune modulation. This article presents a layered assay strategy grounded in recent SCUBE3 findings and practical experimental controls.

• Sulfo-Cy3 NHS Ester in Vascular Assays

  2026-09-29

  Learn how a hydrophilic fluorescent dye can improve protein labeling, endothelial uptake assays, and QD-dye conjugate workflows without requiring organic co-solvents. This practical guide connects Sulfo-Cy3 readouts to the AIBP-LRP2-HDL-miR-223-CXCR4 axis reported in recent collateral-circulation research.

• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-09-29

  The 2021 study by Ali and colleagues identifies combined BRD4 and RAC1 inhibition as a subtype-aware strategy for restricting breast cancer growth, stemness, migration, and tumor formation. Its mechanistic contribution is the connection of JQ1/NSC23766 treatment to disruption of the c-MYC–G9a–FTH1 axis and suppression of HDAC1-associated chromatin regulation.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-09-28

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for amino-containing proteins, peptides, oligonucleotides, and DNA when an organic co-solvent is acceptable. It is water-insoluble and therefore is not the preferred choice for delicate proteins or strictly aqueous labeling workflows.

• TAPRIP Maps circRNA and RNA G-Quadruplex Interactomes

  2026-09-28

  The study introduces TAPRIP, a live-cell proximity-labeling approach that couples miniTurbo to the RNA-targeting element CIRTS3 to profile proteins near selected RNAs by mass spectrometry. Its analyses link HNRNPK to circRNA regulation and identify RBM12 as a BCL2 RNA G-quadruplex-associated factor that supports translation and leukemia-cell growth.

• Puromycin Dihydrochloride in mRNA Therapy Assays

  2026-09-27

  Puromycin dihydrochloride is more than a selection reagent: its rapid interruption of translation can help researchers test how protein production contributes to mRNA-therapy readouts. This article connects its mechanism to a 2026 bladder-cancer p21 mRNA study and explains the opportunities and limits of that experimental bridge.

• Polybrene: Practical Viral Delivery Workflows

  2026-09-26

  Polybrene (Hexadimethrine Bromide) can improve lentiviral and retroviral gene delivery, and may help lipid-mediated transfection in less responsive cells. This guide turns its charge-based action into a controlled optimization workflow, with practical dose-finding, toxicity checks, and a clear distinction between delivery support and biological conclusions.

• Cy3-dCTP Workflows for Fluorescent DNA Labeling

  2026-09-25

  Cy3-dCTP enables direct fluorescent labeling during PCR, Nick Translation, and cDNA synthesis, making it useful for generating probes without a separate post-labeling reaction. This guide translates an ordered-DNA-framework study into practical assay choices while clearly separating its synthesis findings from what has been established for fluorescent nucleotide labeling.

• Cy3 NHS ester (non-sulfonated): Practical Workflow

  2026-09-25

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for amino-containing proteins, peptides, and oligonucleotides when an organic co-solvent can be used. Because it is insoluble in water, it is a poor choice for aqueous-only labeling or delicate biomolecules that cannot tolerate DMSO or DMF.

• Valemetostat (DS-3201) in Lymphoma Research

  2026-09-24

  Valemetostat (DS-3201) gives lymphoma researchers a way to test how EZH1/EZH2-linked H3K27 trimethylation shapes tumor-cell behavior, with workflows that pair target engagement with functional readouts. This guide translates the clinical rationale into practical dose, timing, control, and troubleshooting choices for preclinical studies—not treatment advice.

• Cholesterol in LNP Research: Workflow & Troubleshooting

  2026-09-24

  Use Cholesterol as a controlled formulation variable to connect membrane biology with lipid nanoparticle experiments—without assuming it was the active ingredient in a specific therapy. This guide turns a bladder-cancer mRNA study into practical choices for formulation controls, cell assays, and troubleshooting.

• Cy3 NHS ester (non-sulfonated) Labeling Guide

  2026-09-23

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for biomolecules with accessible primary amines, including proteins, peptides, and appropriately modified oligonucleotides. Its water insolubility makes it a poor choice when a delicate protein cannot tolerate an organic co-solvent; consider a sulfonated NHS ester for those workflows.

7972 records 1/532 page Next 12345 下5页 Last page